Why Travel Concierge Support Makes The Difference For Rare Disease Clinical Trials
By Magdalena Flores Arocena, Manager of Participant Experience, Suvoda

In rare disease trials, populations are small, scattered, and often pediatric, so one dropped participant can end a study, and replacement is frequently impossible. Replacing a single patient in a complex trial can cost more than $150,000 when it can be done at all. Three stories from a rare neuromuscular disease study enrolling infants show what concierge coordinators did over several years: arranging visas across continents, brokering a private home ventilation agreement after a hospital refused discharge, and guiding a Brazilian family through their first flight. Every patient completed the protocol. Should coordinator discretion be treated as part of the protocol itself? Read the stories and judge for yourself.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Tech Leader? Subscribe today.